American Diabetes Association Scientific Sessions

Healio brings you the highlights from the American Diabetes Association Scientific Sessions. Refer back to this page often for the latest news from ADA, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News

CGM lowers health care costs, improves adherence vs. SMBG

July 6, 2018
ORLANDO, Fla. — Among patients with type 1 and type 2 diabetes prescribed multiple daily injection therapy, the use of continuous glucose…
Meeting News

In #MeToo era, ‘blind spots’ persist in endocrinology, clinical sciences

July 5, 2018
ORLANDO, Fla. — As the #MeToo era brings a heightened awareness to endocrinology, academic medicine and the clinical sciences, key gender…
Meeting News

Switch from analogue to human insulin reduces part D coverage gap risk for Medicare beneficiaries

July 3, 2018
ORLANDO, Fla. — Medicare beneficiaries with type 2 diabetes switched from analogue to human insulin were less likely to reach the spending…
Meeting News

Role for dairy in diabetes risk reduction debated

July 2, 2018
ORLANDO, Fla. — A review of prospective, observational studies suggests there is a 4% to 10% decrease in the risk for developing diabetes with…
Meeting News

In type 2 diabetes, clinical inertia persists across health care organizations

July 2, 2018
ORLANDO, Fla. — For patients with type 2 diabetes, a large database analysis suggests a lack of clinical action in the 6 months after an HbA1c…
Meeting News

Experts separate dietary myth from science

June 29, 2018
ORLANDO, Fla. — Eating patterns, such as the Mediterranean diet and the Dietary Approaches to Stop Hypertension, or DASH, diet, are the most…
Meeting News

Semaglutide outperforms dulaglutide across all strata of HbA1c

June 29, 2018
ORLANDO, Fla. — Semaglutide yielded greater HbA1c and weight reductions compared with dulaglutide across all levels of HbA1c, according to
Meeting NewsPerspective

Long-term testosterone therapy may prompt type 2 diabetes remission in men

June 28, 2018
ORLANDO, Fla. — Among men with hypogonadism included in a urology registry, long-term treatment with testosterone may lead to remission of type…
Meeting News

Evolocumab reduces LDL, non-HDL in high-risk patients with type 2 diabetes

June 27, 2018
ORLANDO, Fla. — Treatment with the PCSK9 inhibitor evolocumab on top of maximally tolerated statin therapy resulted in significant reductions…
Meeting News

VADT: After 15 years, a debate over glucose-lowering ‘legacy effect’

June 27, 2018
ORLANDO, Fla. — Long-term follow-up of the Veterans Affairs Diabetes Trial suggests that adults with advanced type 2 diabetes assigned to…

Meeting Calendar

American Diabetes Association Scientific Sessions

June 22, 2018 - June 26, 2018